These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6835381)

  • 21. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
    Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE
    Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies in immunization against hepatitis B.
    Zuckerman AJ
    Hepatology; 1985; 5(6):1227-30. PubMed ID: 4065828
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isolation of a recombinant strain of vaccinia virus containing the pre S2 region of the viral hepatis B surface antigen in its virion].
    Loparev VN; Mitina IV; Araslanov RR; Ivanova ON; Cheliapov NV; Lotte VD; Chernos VI
    Dokl Akad Nauk SSSR; 1989; 306(5):1250-2. PubMed ID: 2791867
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA-based immunization and the immune response to the hepatitis B surface antigen.
    Whalen RG
    Vet Res; 1995; 26(3):217-20. PubMed ID: 7795685
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
    Bennink JR; Yewdell JW; Smith GL; Moller C; Moss B
    Nature; 1984 Oct 11-17; 311(5986):578-9. PubMed ID: 6332992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination against viral hepatitis].
    Grob PJ; Rickenbach M; Joller-Jemelka HI; Steffen R
    ZFA (Stuttgart); 1984 Jan; 60(1):4-9. PubMed ID: 6711081
    [No Abstract]   [Full Text] [Related]  

  • 27. Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector.
    Ramírez JC; Gherardi MM; Rodríguez D; Esteban M
    J Virol; 2000 Aug; 74(16):7651-5. PubMed ID: 10906221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live recombinant vaccinia virus protects chimpanzees against hepatitis B.
    Moss B; Smith GL; Gerin JL; Purcell RH
    Nature; 1984 Sep 6-11; 311(5981):67-9. PubMed ID: 6472464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Working safely with vaccinia virus: laboratory technique and the role of vaccinia vaccination.
    Isaacs SN
    Methods Mol Biol; 2004; 269():1-14. PubMed ID: 15114003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of recombinant vaccinia virus for veterinary vaccines.
    Yilma T
    Dev Biol Stand; 1994; 82():201-9. PubMed ID: 7958475
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunisation of cattle with a recombinant togavirus-vaccinia virus strain.
    Franke CA; Berry ES; Smith AW; Hruby DE
    Res Vet Sci; 1985 Jul; 39(1):113-5. PubMed ID: 3862196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of hepatitis-B vaccines containing intact 20 nm particles.
    Trepo C; Prince AM; Meliconi R; Eddlestone AL; Williams R; Tage-Jensen U; Nielsen JO
    Lancet; 1979 Mar; 1(8114):488. PubMed ID: 85067
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis B: a controllable disease.
    Baker DA; Polk BF
    Obstet Gynecol; 1983 Jul; 62(1):105-8. PubMed ID: 6856210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of 22 nm HBsAG particles by human lymphocytes infected with a recombinant vaccinia virus containing the coding sequence for hepatitis B virus surface antigen.
    Theilmann L; von Brunn A
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1479-84. PubMed ID: 1656954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of vaccinia promoters by heterologous expression of hepatitis B surface antigen in mouse cells infected by recombinant vaccinia viruses.
    Barbeyron T; Mars M; Schroeder E; Malpièce Y; Plucienniczak A; Beaud G; Streeck RE
    Biochim Biophys Acta; 1987 Dec; 910(3):240-4. PubMed ID: 3676323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.
    Andrew ME
    Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():339-41. PubMed ID: 2613281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinia recombinants as vaccine vectors.
    Mahr A; Payne LG
    Immunobiology; 1992 Feb; 184(2-3):126-46. PubMed ID: 1587539
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis virus vaccines: present status.
    Krugman S
    Yale J Biol Med; 1982; 55(3-4):375-81. PubMed ID: 6295013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines.
    Panicali DL; Mazzara G; Sullivan JL; Hesselton R; Shen L; Letvin N; Daniel M; Desrosiers R; Stott EJ
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1449. PubMed ID: 1466979
    [No Abstract]   [Full Text] [Related]  

  • 40. New hepatitis B vaccines.
    Zuckerman AJ
    Br Med J (Clin Res Ed); 1985 Feb; 290(6467):492-6. PubMed ID: 3918647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.